GlassScriptPhysician profile
Aniel Q Majjhoo
NPI 1053552679
$431,621.49
in general payments reported to CMS, 2019-2025
35 companies · $81K in 2025
The $81K reported for 2025 was more than what 99% of Vascular Neurology providers received nationally (typical 2025 total: $360).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $8,539 · 2020: $13K · 2021: $50K · 2022: $92K · 2023: $81K · 2024: $106K · 2025: $81K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $156K · Consulting Fee: $77K · Travel and Lodging: $20K · Food and Beverage: $14K · Entertainment: $26.10.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $156,329.00 |
| Consulting Fee | $77,046.93 |
| Travel and Lodging | $20,287.33 |
| Food and Beverage | $13,625.90 |
| Entertainment | $26.10 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $114,910.32 | 2021-2025 | Pipeline, Solitaire X, Intellis Adaptivestim |
| Stryker Corporation | $89,039.48 | 2019-2025 | Trevo, Surpass Evolve, Infinity |
| Astrazeneca Pharmaceuticals LP | $85,716.45 | 2021-2025 | Andexxa |
| Chiesi USA, INC. | $61,128.54 | 2019-2024 | Cleviprex |
| Qapel Medical INC | $46,353.64 | 2022-2025 | |
| Portola Pharmaceuticals, LLC | $8,089.91 | 2019-2020 | |
| Medical Device Business Services, INC. | $7,619.82 | 2024 | Emboguard |
| Medtronic USA, INC. | $6,638.56 | 2019-2020 | |
| Abbott Laboratories | $3,500.00 | 2020 | |
| Siemens Medical Solutions USA, INC. | $1,323.33 | 2019-2021 | |
| Penumbra, INC. | $1,224.68 | 2019-2022 | |
| Depuy Synthes Sales INC. | $867.10 | 2019-2025 | Embotrap, Cerepak Uniform, Cerebase |
| Microvention, INC. | $840.35 | 2022-2025 | Web Aneurysm Embolization System, Web Detachment Controller |
| Imperative Care, INC | $702.22 | 2019-2024 | Zoom Reperfusion Catheter, Zoom 88-T Large Distal Platform |
| Viz.Ai, INC. | $567.48 | 2022 |
Show all 34 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Balt USA, LLC | $458.53 | 2020-2024 | Ballast 088 Long Sheath |
| Kaneka Medical America LLC | $324.83 | 2023-2025 | Apheresis Machine |
| Boston Scientific Corporation | $324.56 | 2020-2021 | |
| Nevro Corp. | $271.10 | 2021-2022 | |
| Rapid Medical LTD | $232.22 | 2025 | Tigertriever 17 Revascularization Device, Comaneci 17 |
| Inspiremd LTD | $182.70 | 2025 | Cguard Prime Carotid Stent System |
| E.R. Squibb & Sons, L.L.C. | $165.58 | 2019-2024 | Zeposia |
| Alexion Pharmaceuticals, INC. | $165.09 | 2022-2025 | Ultomiris |
| Janssen Pharmaceuticals, INC | $131.08 | 2019-2021 | |
| Genzyme Corporation | $131.07 | 2025 | |
| Horizon Therapeutics Plc | $128.12 | 2021 | |
| Amgen INC. | $124.74 | 2025 | |
| Asahi Intecc USA, INC. | $118.49 | 2025 | Asahi Neurology Wires |
| Impel Pharmaceuticals INC. | $96.67 | 2023 | Trudhesa |
| Neural Analytics, INC. | $68.50 | 2019 | |
| Btg International INC. | $60.42 | 2025 | |
| Pfizer INC. | $55.37 | 2021-2023 | |
| Cardiva Medical, INC. | $42.78 | 2019-2024 | Cardiva Vascade 6/7f Vcs |
| Cordis US Corp. | $17.76 | 2025 | Precise Pro Rx |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Aniel Majjhoo listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.